1 Henry K rum M B, Viskoper RJ, La courciere V, et al.The effects of an endo thelin-receptor antagonist, bosent an, on blood pressure in patients with essential hype rtension.New Engl J Med 1998;3381:7 84
2 Clozel M, Breu V, gray GA, et al.Pharma cological chara cterization of bosentan.a new potent orally active nonpeptide endoThelin receptor ant agonist.J Pharmacol Exper Ther 1994;270:228
3 Veniant M, Clozel JP, Hess P, et al.Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs.Life Sci 1994;56(6): 445
4 Kuc BE, Karet FE, Davenport AP.Char acterization of peptide and nonpeptide antagonists in human kidney.J Cardiovasc Pharmacol 1995, 26 (suppl.3):s 373
5 Lawerence E, brain SD.Effects of BQ 123 and Ro 47-0203 (bo sentan) on endoThelin-1induced vasoconstriction in the rat skin.Eur J Pharmacol 1994;260:103
6 DonckierJ, Stoleru L, Hayshida W, et al.Role of endog enous endo thelin-1 in experimental renal hypertension in dogs.Circulation 1995;92:106
7 Phillips PA, Kisvanis, Aldred K, et al.Differential effects of a novel non-peptide endo thelin receptorantagonist (bosentan)in rat liver and vasculature.Clin Sci Colch 1995;89(6):575
8 WebbRL, Navar rete AE, Ksarder GM.Effects of the ETB 1-selective antagonist IRL 2500 in conscious spontaneously hype rtensive and WistkaKy otorats.J Cardiov asc Pharmacol 1995;2 6 (suppl.3):s 389
9 Balwier czak JL, Brusco CW, Delgrande D, et al. Characterization of a potent and selective endothe-lin-B receptorant agonist, IRL2500.J Cardiov asc Pharmacol 1995;26(suppl.3):s 393
10 Williams DL Jr, Murphy KL, No lan NA, et al. Pharmacology of L-744, 453, a novel nonpeptidyl endothelin antagonist.Life Sci 1996;58(4):1 149
11 Welling s RP, Corder R, Doherty AM, et al. Antagonist of renal and systemic responses to en-so thelin-1 infusion with PD145065.Eur J Pharmacol 1994;2 56:2 01
12 Riechers H, Albrecht HP, Amberg W, et al. Discovery and optimization of a novel class of orally active nonpeptidic endo thelin-A recept or antagonists J Med Chem 1996;3 9:2123
13 Winn M, Geldern TW, Opgenorth TJ, et al. 2, 4-diarylpyrrolidine-3-carboxy licacids-potent ETA selective endothelinre ceptorant agonists.1. Discovery of A-127722.J Med Chem 1996;39: 1039
14 WangQD, Li XS, Lundberg JM, et al.protective effects of nonpeptide endoThelinre ceptorantag onist bosentan an myocardial ischemic and reper fusioninjury in the pig.Cardiov asc Res 1995;29(6): 805
15 王峰, 杨连春, 刘敏, 等.抗蛇毒中草药拮抗ET-1和S 6b 作用的初步研究中国中药杂志1997;22(10):620
16 王峰, 杨连春, 程言亮, 等.红背丝绸提取物和单体CA-1201 对内皮素-1 效应的拮抗作用.中国药学杂志1988;3 3(6):337
17 季小慎,王峰, 王京媛, 等.肉桂酰胺类似物的合成及其对内皮素-1 生物效应的拮抗作用.中国药物化学杂志1998;8(4):2 50
18 Yang Lianchun, Wang Feng, Liu Min, et al. Study of an endo thelin antagonist from a Chinese anti-snake venom medicinal herb.J Cardiovasc Pharmacol 1998;3 1(suppl.1):s249 |
